We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$488M
AUM Growth
-$122M
Cap. Flow
-$46M
Cap. Flow %
-9.42%
Top 10 Hldgs %
12.26%
Holding
885
New
278
Increased
177
Reduced
136
Closed
293

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$7.96M
2
MSFT icon
Microsoft
MSFT
+$6.24M
3
EL icon
Estee Lauder
EL
+$5.96M
4
CSCO icon
Cisco
CSCO
+$5.04M
5
WBA
Walgreens Boots Alliance
WBA
+$4.16M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Consumer Discretionary 16.56%
3 Healthcare 14.16%
4 Industrials 11.69%
5 Consumer Staples 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECPG icon
476
Encore Capital Group
ECPG
$2.03B
$235K 0.05%
9,982
-7,118
-42% -$191K
AMP icon
477
Ameriprise Financial
AMP
$47.6B
$233K 0.05%
2,233
-1,543
-41% -$194K
HTT
478
High Templar Tech Ltd
HTT
$376M
$232K 0.05%
+54,000
New +$258K
ADMS
479
DELISTED
Adamas Pharmaceuticals
ADMS
$232K 0.05%
27,168
-700
-3% -$9.1K
DNOW icon
480
DNOW Inc
DNOW
$2.59B
$230K 0.05%
19,800
-1,500
-7% -$21K
ARCB icon
481
ArcBest
ARCB
$3.31B
$228K 0.05%
+6,658
New +$258K
SUPN icon
482
Supernus Pharmaceuticals
SUPN
$2.73B
$228K 0.05%
6,877
-300
-4% -$12.9K
THS
483
DELISTED
Treehouse Foods
THS
$228K 0.05%
4,500
-11,300
-72% -$557K
CP icon
484
Canadian Pacific Kansas City
CP
$81.1B
$227K 0.05%
+6,395
New +$256K
MTW icon
485
Manitowoc
MTW
$523M
$226K 0.05%
15,319
+100
+0.7% +$1.87K
CNO icon
486
CNO Financial Group
CNO
$4.96B
$225K 0.05%
+15,100
New +$275K
GMS
487
DELISTED
GMS Inc
GMS
$225K 0.05%
+15,169
New +$266K
NVTA
488
DELISTED
Invitae Corporation
NVTA
$225K 0.05%
20,300
+5,700
+39% +$73.9K
RAD
489
DELISTED
Rite Aid Corporation
RAD
$225K 0.05%
+15,890
New +$335K
HURN icon
490
Huron Consulting
HURN
$1.89B
$224K 0.05%
+4,367
New +$222K
UIS icon
491
Unisys
UIS
$245M
$224K 0.05%
19,300
-3,900
-17% -$61.4K
EQR icon
492
Equity Residential
EQR
$25.2B
$223K 0.05%
3,383
-2,689
-44% -$181K
MBUU icon
493
Malibu Boats
MBUU
$557M
$223K 0.05%
6,414
-4,600
-42% -$202K
OEC icon
494
Orion
OEC
$379M
$222K 0.05%
8,800
-4,000
-31% -$104K
SBGI icon
495
Sinclair Inc
SBGI
$974M
$221K 0.05%
+8,400
New +$245K
SAGE
496
DELISTED
Sage Therapeutics
SAGE
$219K 0.04%
+2,290
New +$262K
EGRX
497
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$219K 0.04%
+5,434
New +$280K
BANR icon
498
Banner Corp
BANR
$2.39B
$216K 0.04%
+4,041
New +$235K
NMIH icon
499
NMI Holdings
NMIH
$3.27B
$216K 0.04%
+12,101
New +$236K
GTN icon
500
Gray Television
GTN
$409M
$215K 0.04%
+14,564
New +$253K

Similar funds

Bayesian Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bayesian Capital Management held 885 positions worth $488M, down 20% from $611M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $46M in Q4 2018, closing 293 positions and reducing 136 holdings. Its most notable exit was Lowe's Companies, an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Nike worth $7.89M.

  • Bayesian Capital Management's largest Q4 2018 buy was Nike: 106,400 shares worth $7.89M.
  • Bayesian Capital Management added most to Microsoft in Q4 2018, an estimated $6.24M increase.
  • Bayesian Capital Management's biggest Q4 2018 reduction was lululemon athletica, cutting an estimated $6.86M.
  • Bayesian Capital Management fully exited Lowe's Companies in Q4 2018, selling an estimated $6.56M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $488M portfolio in Q4 2018.
  • Bayesian Capital Management opened 278 new positions and closed 293 in Q4 2018.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $488M.

Based on Bayesian Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.